- Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 08, 2024€14.35 (+10.81%)Earnings
- Q4 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJan 31, 2024€11.05 (+2.31%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 08, 2023€8.82 (+3.28%)Earnings
- Teva Pharmaceutical Industries Ltd to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 02, 2023€8.42 (+11.38%)Earnings
- Teva Pharmaceutical Industries Ltd Investor Day TranscriptMay 18, 2023
- Q1 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 10, 2023€7.28 (-11.65%)Earnings
- Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 08, 2023€9.66 (-4.83%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 03, 2022€8.86 (-3.06%)Earnings
- Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 27, 2022€8.8 (+24.29%)Earnings
- Q1 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 03, 2022€8.24 (+3.00%)Earnings
- Q4 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 09, 2022€7.86 (+8.26%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptOct 27, 2021€7.76 (-4.32%)Earnings
- Q2 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 28, 2021€8.48 (+12.02%)Earnings
- Q1 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptApr 28, 2021€8.38 (-1.30%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 10, 2021€10.82 (+1.31%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 05, 2020€7.22 (-5.87%)Earnings
- Q2 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 05, 2020€10.42 (+1.76%)Earnings
- Q1 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 07, 2020€10.68 (+12.66%)Earnings
- Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 12, 2020€12.42 (+8.76%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 07, 2019€7.8 (+4.56%)Earnings
- Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 07, 2019€6.38 (+0.63%)Earnings
- Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 02, 2019€13.25 (-2.57%)Earnings
- Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 13, 2019€15.69 (-6.88%)Earnings
Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Teva Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your first speaker today, Kevin Mannix, Senior Vice President of Investor Relations. Please go ahead.
Thank you, Nadia, and thanks, everyone, for joining us today to discuss Teva's third quarter 2021 financial results. Joining me on today's call is Kare Schultz, Teva's Chief Executive Officer; Eli Kalif, Chief Financial Officer; and Dr. Sven Dethlefs, Teva's Head of North America Commercial. We hope you've had an opportunity to review our press release, which was issued about an hour ago. A copy of the release and the slides being presented on this call can be found on our website at www.tevapharm.com.
Please note that the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)